KPV
January 10, 2024Incremental
4/10
Purrptide digest
KPV is tiny — just three amino acids, the smallest peptide on this entire list. And yet it's a fragment of alpha-MSH that retains real anti-inflammatory power. Animal studies show it calming colitis and gut inflammation specifically, without the immunosuppression baggage that comes with steroids. It's small enough to potentially survive oral delivery, which would be a genuinely big deal for a peptide — most get destroyed by stomach acid before they do anything.
What this means for you
🏃
If you care about weight/health
If gut inflammation is your issue, this is one of the more promising peptide angles — though human data is still thin.
🩺
If you're a clinician
Anti-inflammatory action without broad immunosuppression is the differentiator from steroid-based IBD treatment. Worth watching for human trials.
🔬
If you're a researcher
Potential oral bioavailability due to its tiny size is the more interesting story than the anti-inflammatory effect itself.
💸
If you follow biotech
An oral-viable anti-inflammatory peptide for IBD would be a genuinely big commercial opportunity if it survives human trials.
DA
Dalmasso et al.
Emory University
For the nerds
The melanocortin agonist KPV ameliorates intestinal inflammation
American Journal of Physiology · DOI: 10.1152/ajpgi.90524.2008
Read full paper on PubMed →